Vivendi: Shares Plunge Nearly 6%, Erasing Recent Gains Amid Bolloré-CIAM Legal Battle
Vivendi's stock heavily declines at midday in Paris, while the Parisian market overall advances. The stock erases most of its recent rebound, in a context where the legal case between CIAM fund and Vincent Bolloré continues to dominate the attention of traders.
Vivendi Drops Nearly 6% and Ranks Among the Biggest Declines in the SBF 120
Vivendi SE shares drop 5.89% to €2.17, down from €2.31 the previous day. The stock is among the biggest losers in the SBF 120, while the broader index is up by 0.83% and the CAC 40 advances by 0.88% during the session. The decline cuts a large part of the monthly gain, which still stands at +9.42%, and brings the weekly loss to 5.73%. Over the year, the stock is down by 24.11%.
This movement follows the speculations that emerged at the end of May about a possible public offer, after the disclosure of an internal email from the Bolloré group dated 2017 presented to the Paris Court of Appeal in the dispute between the CIAM fund and Vincent Bolloré. On May 29, the stock had soared more than 5% on this issue; today's session cancels a large part of this surge.
Price Falls Below Its 20-Day Moving Average and Moves Away from Its MM200
The decline brings the price below the 20-day moving average (€2.25), with a gap of -3.47%. However, the 50-day moving average is still exceeded (€2.09), at +3.92% of the price, indicating that the medium-term momentum is not yet broken. The 200-day moving average, at €2.48, remains distant (-12.42%) and reflects the underlying bearish trend observed over the year. The RSI at 61 remains in neutral territory, which leaves room before a decisive technical signal.
The identified support at €1.95 is the next graphical reference in case the decline continues, with resistance located at €2.36. With a monthly volatility close to 9.75%, the stock remains sensitive to the twists and turns of the CIAM-Bolloré legal case, which largely conditions the trading decisions on the stock.